Sandra Milligan - 01 May 2022 Form 4 Insider Report for Organon & Co. (OGN)

Role: Head of Research & Development
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Sandra Milligan
Issuer symbol: OGN
Transactions as of: 01 May 2022
Net transactions value: -$17,458
Form type: 4
Filing time: 03 May 2022, 19:40:19 UTC
Previous filing: 04 Apr 2022
Next filing: 05 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise		+1,896	+20%		11,276	01 May 2022	Direct	F1
transaction	OGN	Common Stock	Tax liability	$17,458	-540	-4.8%	$32.33	10,736	01 May 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	-1,896	-50%	$0.000000	1,896	01 May 2022	Common Stock	1,896		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023.
F2	The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations.